Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. (2024)
Attributed to:
The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(23)00298-9
PubMed Identifier: 38267107
Publication URI: http://europepmc.org/abstract/MED/38267107
Type: Journal Article/Review
Volume: 6
Parent Publication: The Lancet. Rheumatology
Issue: 2
ISSN: 2665-9913